Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTPRD divergent transcript (PTPRD-DT) is a long non-coding RNA transcribed from the strand opposite to the PTPRD gene on chromosome 9. It is also called PTPRD-AS2, reflecting its antisense relationship to the protein-coding PTPRD gene. While PTPRD (protein tyrosine phosphatase receptor type D) is a well-studied tumor suppressor and neurobiological target, PTPRD-DT appears to function through regulation of gene expression at the RNA level rather than encoding a functional protein. There is currently little direct knowledge of its independent biological or disease functions, and it is not targeted by approved therapeutics[8]. Key Distinction: Do not confuse PTPRD-DT (a non-coding regulatory RNA) with PTPRD (a receptor-type protein tyrosine phosphatase, a validated drug and disease target), as their functional relevance and targetability differ fundamentally. If you need information about the protein-coding PTPRD gene itself, please specify.
Not applicable. No direct drug mechanisms are described for this RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PTPRD divergent transcript (PTPRD-DT).